Cellectar Biosciences (CLRB) Q3 2024 Earnings
CLRB·Reported October 29, 2024·Before market open
Diluted EPS came in at $-0.51, missed the $-0.37 consensus by $0.14.
Diluted EPS
$-0.51missed by $0.14
Consensus: $-0.37
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Cellectar Biosciences's Q3 2024 earnings report.
Cellectar Biosciences (CLRB) reported Q3 2024 earnings on October 29, 2024 before market open.
Cellectar Biosciences reported diluted EPS of $-0.51 for Q3 2024.
EPS missed the consensus estimate of $-0.37 by $0.14.
You can read the 10-Q periodic report (0001410578-24-001708) directly on SEC EDGAR. The filing index links above go to sec.gov.